Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.
Kennedy Institute of Rheumatology, University of Oxford, United Kingdom.
Head Neck. 2020 Sep;42(9):2375-2389. doi: 10.1002/hed.26244. Epub 2020 May 14.
Human papillomavirus (HPV) oncogenes E6, E7, and shorter isoforms of E6 (E6*) are known carcinogenic factors in head and neck squamous cell carcinoma (HNSCC). Little is known regarding E6* functions.
We analyzed RNA-seq data from 68 HNSCC HPV type 16-positive tumors to determine host genes and pathways associated with E6+E7 expression (E6E7) or the percent of full-length E6 (E6%FL). Influence scores of E6E7 and E6%FL were used to test for associations with clinical variables.
For E6E7, we recapitulated all major known affected pathways and revealed additional pathways. E6%FL was found to affect mitochondrial processes, and E6%FL influence score was significantly associated with overall survival and tumor size.
HPV E6E7 and E6* result in extensive, dose-dependent compensatory effects and dysregulation of key cancer pathways. The switch from E6 to E6* promotes oxidative phosphorylation, larger tumor size, and worse prognosis, potentially serving as a prognostic factor for HPV-positive HNSCC.
人乳头瘤病毒(HPV)致癌基因 E6、E7 和 E6 的较短亚型(E6*)是头颈部鳞状细胞癌(HNSCC)的致癌因素。关于 E6* 的功能知之甚少。
我们分析了 68 例 HPV 型 16 阳性 HNSCC 肿瘤的 RNA-seq 数据,以确定与 E6+E7 表达(E6E7)或全长 E6 的百分比(E6%FL)相关的宿主基因和途径。E6E7 和 E6%FL 的影响评分用于测试与临床变量的关联。
对于 E6E7,我们重现了所有主要已知的受影响途径,并揭示了其他途径。发现 E6%FL 会影响线粒体过程,E6%FL 影响评分与总生存期和肿瘤大小显著相关。
HPV E6E7 和 E6* 导致广泛的、剂量依赖性的补偿效应和关键癌症途径的失调。从 E6 到 E6* 的转变促进氧化磷酸化、更大的肿瘤大小和更差的预后,可能成为 HPV 阳性 HNSCC 的预后因素。